Skip to main content
WG2 Leader

Prof Anna Golebiewska

About

Development of more accurate genetically engineered mouse models (GEMMs), and patient-derived orthotopic xenografts models (PDOXs), as well as 3D systems (neurosphere, organoids and bioprinting) should contribute to a better understanding of brain tumour mechanisms.

Research focus

Preclinical Models

Development of more accurate genetically engineered mouse models (GEMMs), and patient-derived orthotopic xenografts models (PDOXs), as well as 3D systems (neurosphere, organoids and bioprinting) should contribute to a better understanding of brain tumour mechanisms.

Connect

LinkedIn profile